According to the most recent Future Market Insights (FMI) report, the female pelvic implants market will be worth $245 million in 2021. The overall sales picture remains good, with female pelvic implant demand expected to reach US$ 322.6 million by 2031, as the market grows at a CAGR of 2.8% between 2021 and 2031.
According to the American Urological Association (AUA/SUFU), up to 49% of women suffer from stress urinary incontinence (SUI). Stress urine incontinence is more common in women who have poor or weaker pelvic supports. This condition has a significant impact on the lives of women and is common in the elderly.
Get Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-3422
The rising prevalence of vaginal problems among elderly women, combined with the lack of effective therapeutic options for SUI and POP, will drive demand for female pelvic implants. According to the US Food and Drug Administration, the number of women with POP is expected to increase by 46% by 2050, to 4.9 million.
Key Takeaways from Female Pelvic Implants Market Study
- Because of the strong demand to treat stress urinary incontinence, vaginal sling/tapes are estimated to reach a maximum revenue share of more than 68%, rising at a CAGR of 2.5%.
- Because of the growing number of POP and SUI patients, hospitals are the most common users of female pelvic implants, followed by ambulatory surgery centres.
- Because of the high prevalence of pelvic organ prolapse, the United States accounts for more than 83% of the North American market.
- The United Kingdom is Europe’s top market. It is predicted to account for roughly 13% of European consumption by 2031. The implementation of government-funded awareness programmes will continue to be a major development driver.
- India controls more than 30% of the South Asian market. Significant investments in the expansion of the healthcare industry are propelling the country’s growth.
Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-3422
Post-Marketing Surveillance of Approved Devices Influencing Female Pelvic Implants Demand
Despite legal restrictions, an increasing number of firms continue to offer their products on the worldwide market. Following the FDA’s reclassification of vaginal mesh implants from Class II to Class III medical devices, the FDA directed 33 manufacturers to conduct three-year studies to investigate the effects of organ damage and other mesh implant problems.
After considering the hazards, producers can reintroduce their products and obtain FDA pre-market approval. This allows manufacturers to reintroduce mesh implants, which are slated to hit the market in 2022.
Who is Winning?
The market’s key players are focusing on strategic alliances, acquisitions, and expansion. Product releases, agreements, and research sponsorships are among important techniques used by manufacturers to strengthen their product portfolios in the female pelvic implants industry.
Coloplast, for example, bought Nine Continents Medical, Inc. in November 2020 with the intention of expanding its medical device product line.
The FDA completed its thorough examination of data linked with the resin used in the fabrication of Boston Scientific’s vaginal mesh in 2019. US federal law restricts the sale of these devices to orders from a surgeon.
Want More Insights?
Future Market Insights (FMI) delivers a complete research study on predicted revenue growth at the global, regional, and country levels, as well as an analysis of the most recent industry trends in each sub-segment from 2016 to 2031. The global Female Pelvic Implants Market is categorised in depth to cover every area of the market and provide the reader with a comprehensive market intelligence approach. The analysis offers fascinating insights into the Female Pelvic Implants Market by product type [Vaginal Mesh Implants, Vaginal Sling/Tape, and Vaginal Graft Implants] and indication [Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI)]. End User [Hospitals, Ambulatory Surgical Centers, and Specialized Clinics] data from seven major regions.
Buy Complete Report@ https://www.futuremarketinsights.com/checkout/3422
Market Taxonomy Product Type
- Vaginal Mesh Implants
- Vaginal Sling
- Vaginal Graft Implants
Indication
- Pelvic Organ Prolapse
- Stress Urinary Incontinence
End User
- Hospitals
- Ambulatory Surgical Centres
- Speciality Clinics
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs